J4 ›› 2010, Vol. 36 ›› Issue (2): 349-353.

• 基础研究 • 上一篇    下一篇

20(s)-原人参二醇对前列腺癌RM-1细胞的生长抑制作用及其机制

郭亚雄1|刘艳波1,2|李德龙1|韩向北1|许多1|程宏1|赵丽晶1|赵丽娟1|董妍3   

  1. 1. 吉林大学基础医学院病理生理学教研室,吉林 长春 130021; 2.北华大学基础医学院病理生理学教研室,吉林 吉林 132001; 3.美国杜兰大学细胞生物学教研室,美国 新奥尔良 LA70062
  • 出版日期:2010-03-28 发布日期:2010-04-04
  • 通讯作者: 赵丽娟(Tel:0431-85619485,E-mail:titan2003@sina.com.cn); 董 妍(Tel:001-4007128899-8991088195,E-mail:drdong71@gmail.com) E-mail:titan2003@sina.com.cn;drdong71@gmail.com
  • 作者简介:郭亚雄(1980-)|男|河北省张家口市人,在读医学博士,主要从事前列腺癌防治研究。
  • 基金资助:

    吉林省人民政府人才开发基金资助课题(2006JD02)

Growth inhibition of 20(s)-protopanaxadiol on prostate cancer cells RM-1 in mice and its mechanism

GUO Ya-Xiong1, LIU Yan-Bo1,2, LI De-Long1, HAN Xiang-Bei1, XU Duo1, CHENG Hong1, ZHAO Li-Jing1, ZHAO Li-Juan1, DONG Yan3   

  1. 1. Department of Pathophysiology,School of Basic Medical Sciences,Jilin University,Changchun 130021,China;2. Department of Pathophysiology,School of Basic Medical Sciences,Beihua University,Jilin 132001,China;3. Department of Structural and Cellular Biology,Tulane University,New Orleans LA 70062,USA
  • Online:2010-03-28 Published:2010-04-04

摘要:

目的:观察20(s)-原人参二醇(PPD)对前列腺癌RM-1细胞生长的影响,并探讨其作用机制。方法:建立前列腺癌RM-1细胞动物模型,将36只C57小鼠随机分为3组:模型组(橄榄油等体积灌胃每天1次、生理盐水等体积腹腔注射每周1次),紫杉醇(Taxol)组(20 mg/kg,腹腔注射每周1次),PPD组(20 mg/kg,灌胃每天1次),连续给药4周。每隔3 d测量肿瘤体积1次,给药第4周末处死动物。观察指标:动物一般状态、肿瘤体积、瘤重、抑瘤率、死亡率,采用RT-PCR和Western blotting法检测肿瘤组织Cyclin D1蛋白表达水平。结果:PPD组小鼠一般状态明显好于模型组,表现为活泼好动、毛色光亮;而模型组小鼠步履蹒跚、行动迟缓、精神萎靡;肿瘤组织出现破溃、糜烂、出血。给药13 d时,PPD组小鼠肿瘤体积明显减小(P<0.05);21 d时PPD组肿瘤体积明显小于Taxol组(P<0.05)。与模型组比较,PPD组小鼠瘤质量明显降低(P<0.05),死亡率为零;与Taxol组比较,PPD组小鼠抑瘤率增高(P<0.05),死亡率降低(P<0.05)。各给药组小鼠肿瘤组织Cyclin D1基因转录、蛋白表达水平均明显低于模型组(P<0.05),与Taxol组比较,PPD组Cyclin D1基因转录明显减弱(P<0.05),而蛋白表达水平差异无显著性(P>0.05)。结论:PPD有明显抑制前列腺癌RM-1细胞生长的作用,其作用机制可能与下调Cyclin D1蛋白表达有关。

关键词: 20(s)-原人参二醇;前列腺肿瘤;细胞周期蛋白D1

Abstract:

Abstract:Objective To observe the effects of  20(s)-protopanaxadiol (PPD) on the growth of prostate cancer cells RM-1 and explore the mechanism of its action.Methods The mouse models with prostate cancer were constructed with RM-1 cells.36 mice C57 were randomly divided into three groups:model group(fed with  an equal volume of olive oil once a day,an equal volume of normal saline injection  intraperitoneal  once a week),paclitaxel(Taxol) group(20 mg/kg,intraperitoneal injection  once a week),PPD group(20 mg/kg,ig once a day),continuous administration of 4 weeks.The tumor size was measured once every 3 d,and the morphological changes of tumor were observed,the animals were killed over the fourth weekend.Observation:the general state of animal tumor weight,tumor volume,inhibitory rate,mortality;and the expression of Cyclin D1 gene was detected with RT-PCR and Western blotting.Results Compared with model group,the tumor growth of mice in other groups significantly slowed down,and the mice in PPD group had bright hair.The mice in  model group  scrambled and moved slowly with tumor ulceration,erosion and hemorrhage.The tumor volume of the mice in PPD group was significantly smaller than that in model group(P<0.05) 13 d after administration,and it was also significantly smaller than that in Taxol group(P<0.05) 21 d after administration.Compared with model group,the tumor weight of the mice in PPD group was significantly decreased(P<0.05),but the inhibitory rate was significantly increased(P<0.05),no death.Compared with Taxol group,the inhibitory rate in PPD group was significantly increased(P<0.05),the mortality was significantly decreased(P<0.05).The RT-PCR and Western blotting results showed that Cyclin D1 gene and protein expressions in treatment  groups were significantly reduced(P<0.05)compared with model group;compared with Taxol group,the expression of Cyclin D1 in PPD group was significantly decreased(P<0.05),but there was no significant difference of Cyclin D1 protein expression between PPD group and Taxol group(P>0.05).Conclusion PPD can significantly inhibit the growth of prostate cancer cells RM-1 and its mechanism may be related to the down-regulation of the expression of Cyclin D1.

Key words: 20(s)-protopanaxadiol;prostate neoplasms;Cyclin D1

中图分类号: 

  • R737.25